Douglas Fambrough, Chief Executive Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 78,569 shares at $25.85 ($2.0M) on 2019-12-18, disclosed to the SEC on 2019-12-19.
Open-market sale of $2.0M DRNA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DRNA | SELL | 2019-12-19 | $7.2M | — | Filing → |
| DRNA | SELL | 2019-12-19 | $1.5M | — | Filing → |
| DRNA | BUY | 2016-11-16 | $123K | — | Filing → |